ENTPD1 and fibrosarcoma: In a 2015 study, Dr. Hayes and colleagues used mass spectrometry and immunohistochemistry (IHC) to demonstrate CD39 expression in sarcomas such as liposarcoma, fibrosarcoma, dermatofibrosarcoma, and leiomyosarcoma.